Finance

Beta
Lists
CLYM:NASDAQ
Climb Bio Inc
၁၂.၇၈ US$
+၀.၂၁%
(+၀.၀၂၇) 1D
ဇွန် ၂၅, GMT-၄ ၀၉:၃၂:၅၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLYM...
Open
၁၂.၇၅ US$
High
၁၂.၉၆ US$
Low
၁၂.၇၄ US$
Mkt. cap
၇၃.၉၆ ကုဋေ
Avg. vol.
၁.၀၇ သန်း
Volume
၁.၄၆ ထောင်
52-wk high
၁၂.၉၆ US$
52-wk low
၁.၁၈ US$
EPS
-၀.၇၈ US$
Beta
၀.၁၂
Shares outstanding
၅.၇၃ ကုဋေ
No. of employees
၂၉
Open
၁၂.၇၅ US$
High
၁၂.၉၆ US$
Low
၁၂.၇၄ US$
Mkt. cap
၇၃.၉၆ ကုဋေ
Avg. vol.
၁.၀၇ သန်း
Volume
၁.၄၆ ထောင်
52-wk high
၁၂.၉၆ US$
52-wk low
၁.၁၈ US$
EPS
-၀.၇၈ US$
Beta
၀.၁၂
Shares outstanding
၅.၇၃ ကုဋေ
No. of employees
၂၉
News stories
From sources across the web
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၁ ရက်
Climb Bio stock price target reiterated at $20 by H.C. Wainwright
GuruFocus
GuruFocus
·
ပြီးခဲ့သည့် ၁ ရက်
CLYM Reiterated by HC Wainwright & Co. -- Price Target Maintained at $20
About Climb Bio Inc
CEO-
Employees၂၉
Founded၂၀၁၈
HeadquartersWellesley Hills, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteclimbbio.com
Analyst Ratings
Based on 13 analysts giving stock ratings to CLYM in the past 3 months
Strong Buy
Buy
13
Hold
0
Sell
0
12 month forecast
Based on 13 Wall Street analysts offering 12 month price targets for CLYM in the last 3 months.
Highest
Current ၁၂.၇၈ US$
၃၅.၀၀ US$ (+၁၇၃.၉၃%)
Average
၂၁.၅၆ US$ (+၆၈.၇၄%)
Lowest
၁၇.၀၀ US$ (+၃၃.၀၅%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Christopher Raymond
Raymond James
Buy
Maintained
-
-
06/24/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
၂၀.၀၀ US$
+၅၆.၅%
06/24/2026
Laura Chico
Wedbush
Buy
Maintained
၁၇.၀၀ US$
+၃၃.၁%
06/12/2026
Thomas Smith
Leerink Partners
Buy
Reiterated
-
-
06/12/2026
Julian Harrison
BTIG
Buy
Maintained
၂၀.၀၀ US$
+၅၆.၅%
06/11/2026
Matt Phipps
William Blair
Buy
Reiterated
-
-
06/11/2026
Yatin Suneja
Guggenheim
Buy
Initiated
၃၅.၀၀ US$
+၁၇၃.၉%
06/08/2026
Danielle Brill
Truist Financial
Buy
Maintained
-
-
06/02/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
၂၃.၀၀ US$
+၈၀%
05/19/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
၁၈.၀၀ US$
+၄၀.၉%
05/15/2026
Colleen M. Kusy
Robert W. Baird
Buy
Maintained
၂၁.၀၀ US$
+၆၄.၄%
05/06/2026
Geulah Livshits
Chardan Capital
Buy
Maintained
၂၂.၀၀ US$
+၇၂.၂%
05/05/2026
Joseph Catanzaro
Mizuho Securities
Buy
Initiated
၁၈.၀၀ US$
+၄၀.၉%
04/15/2026
Mayank Mamtani
B. Riley Securities
Buy
Initiated
၂၆.၀၀ US$
+၁၀၃.၅%
03/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၆.၅၈ သန်း
၉.၀၇ သန်း
၁.၃၇ ကုဋေ
၉.၃၇ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄.၁၀ သန်း
၅.၈၂ သန်း
၅.၅၆ သန်း
၅.၈၄ သန်း
Operating expense
၁.၀၇ ကုဋေ
၁.၄၉ ကုဋေ
၁.၉၃ ကုဋေ
၁.၅၂ ကုဋေ
Total operating expenses
၁.၀၇ ကုဋေ
၁.၄၉ ကုဋေ
၁.၉၃ ကုဋေ
၁.၅၂ ကုဋေ
Operating income
-၁.၀၇ ကုဋေ
-၁.၄၉ ကုဋေ
-၁.၉၃ ကုဋေ
-၁.၅၂ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
-၈.၆၇ သန်း
-၁.၂၉ ကုဋေ
-၁.၇၅ ကုဋေ
-၁.၃၇ ကုဋေ
EBT excluding unusual items
-၈.၆၇ သန်း
-၁.၂၉ ကုဋေ
-၁.၇၅ ကုဋေ
-၁.၃၇ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၈.၆၇ သန်း
-၁.၂၉ ကုဋေ
-၁.၇၅ ကုဋေ
-၁.၃၇ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-
-၀.၁၉
-၀.၂၆
-၀.၂၀
Interest and investment income
၂.၁၇ သန်း
၂.၀၄ သန်း
၁.၈၃ သန်း
၁.၅၁ သန်း
Interest expense
-
-
-
-
Net interest expenses
၂.၁၇ သန်း
၂.၀၄ သန်း
၁.၈၃ သန်း
၁.၅၁ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၀၇ ကုဋေ
-၁.၄၉ ကုဋေ
-၁.၉၃ ကုဋေ
-၁.၅၂ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer